Usually, scientists study the molecular biology of cancer to find new treatments, but sometimes, it is the other way around: When seeking new treatments, scientists find key information on cancer biology. The researchers ...
Jun 13, 2019
0
6
Every year, 4 million new cases of cancer are diagnosed in Europe. Advances in cancer treatment sometimes come at the cost of major adverse effects, and one of the most prominent is cardiotoxicity. Myocardial toxicity affects ...
Feb 19, 2019
0
2
Hokkaido University researchers have engineered a virus that selectively targets and kills cancer cells. The virus, called dl355, has an even stronger anticancer effect than another engineered virus currently used in clinical ...
Jan 29, 2019
0
5
An antibody that targets and is taken up only by certain types of cancer cells has been developed by A*STAR researchers. Combining this antibody with an anticancer drug could lead to a new treatment for some types of breast ...
Jan 15, 2019
0
13
Anticancer vaccines have gained a new lease of life with techniques to personalise them to individual patients. Cutting edge developments in this re-energised field were revealed at the ESMO Immuno-Oncology Congress in Geneva, ...
Dec 19, 2018
0
1
Wrapping an anticancer drug in a nanoscale case made of a polymer and a component of green tea is an extremely effective way to deliver high doses of the drug to tumors, an A*STAR team has shown. They demonstrated the system's ...
Aug 8, 2018
0
0
When scientists at The University of Texas Health Science Center at Houston (UTHealth) applied a chemical found in soybeans to a non-steroidal anti-inflammatory drug (NSAID), they increased its anticancer properties and reduced ...
May 30, 2018
0
5
Angiogenesis, the formation of new blood vessels, is essential for tumor growth. A new study reported in The American Journal of Pathology describes a vascular stabilization biomarker that can visualize blood vessel activity, ...
Apr 9, 2018
0
13
Scientists from the Universities of Bristol and Parma, Italy, have used molecular simulations to understand resistance to osimertinib - an anticancer drug used to treat types of lung cancer.
Feb 12, 2018
0
63
Colorectal cancer is one of the most common cancers in the developed world. Although the five-year survival rates for earlier stages of this cancer are relatively high, at later stages, survival drops and the risk of cancer ...
Jan 11, 2018
0
812
